Which has stronger earnings and valuation, ALC or COO?

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Alcon $10.40B 3.50 $980M $1.31 56.25 Cooper Companies $4.23B 3.49 $374.90M $1.18 64.24

Is ALC or COO more profitable?

Alcon has a net margin of 5.92% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity. Company Net Margins Return on Equity Return on Assets Alcon 5.92% 7.29% 5.09% Cooper Companies 5.57% 10.88% 7.27%

Does the media prefer ALC or COO?

In the previous week, Cooper Companies had 32 more articles in the media than Alcon. MarketBeat recorded 34 mentions for Cooper Companies and 2 mentions for Alcon. Cooper Companies' average media sentiment score of 1.06 beat Alcon's score of 0.41 indicating that Cooper Companies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Alcon 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Cooper Companies 23 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media prefer COO or MDLN?

In the previous week, Cooper Companies had 23 more articles in the media than Medline. MarketBeat recorded 34 mentions for Cooper Companies and 11 mentions for Medline. Cooper Companies' average media sentiment score of 1.06 beat Medline's score of 0.20 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 23 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Medline 3 Very Positive mention(s) 1 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media refer more to WST or COO?

In the previous week, Cooper Companies had 14 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 34 mentions for Cooper Companies and 20 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.70 beat Cooper Companies' score of 1.06 indicating that West Pharmaceutical Services is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment West Pharmaceutical Services 20 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Very Positive Cooper Companies 23 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Does the media favor COO or SOLV?

In the previous week, Cooper Companies had 30 more articles in the media than Solventum. MarketBeat recorded 34 mentions for Cooper Companies and 4 mentions for Solventum. Cooper Companies' average media sentiment score of 1.06 beat Solventum's score of 0.95 indicating that Cooper Companies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Cooper Companies 23 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive Solventum 1 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media prefer ALGN or COO?

In the previous week, Cooper Companies had 24 more articles in the media than Align Technology. MarketBeat recorded 34 mentions for Cooper Companies and 10 mentions for Align Technology. Align Technology's average media sentiment score of 1.17 beat Cooper Companies' score of 1.06 indicating that Align Technology is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Align Technology 8 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Cooper Companies 23 Very Positive mention(s) 3 Positive mention(s) 5 Neutral mention(s) 2 Negative mention(s) 1 Very Negative mention(s) Positive

Cooper Companies (COO) Competitors

$75.80 -0.42 (-0.55%)

Closing price 04:00 PM Eastern

Extended Trading

$76.66 +0.86 (+1.13%)

As of 06:04 PM Eastern

Compare

COO vs. ALC, MDLN, WST, SOLV, and ALGN

Should you buy Cooper Companies stock or one of its competitors? Cooper Companies's main competitors and comparable companies include Alcon (ALC), Medline (MDLN), West Pharmaceutical Services (WST), Solventum (SOLV), and Align Technology (ALGN). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare supplies" industry.

How does Cooper Companies compare to Alcon?

Alcon (NYSE:ALC) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their valuation, dividends, institutional ownership, profitability, earnings, media sentiment, analyst recommendations and risk.

Alcon currently has a consensus price target of $84.96, suggesting a potential upside of 15.31%. Cooper Companies has a consensus price target of $81.64, suggesting a potential upside of 7.71%. Given Alcon's stronger consensus rating and higher probable upside, equities analysts clearly believe Alcon is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Alcon	1 Sell rating(s)	6 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.63
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

53.9% of Alcon shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 2.1% of Cooper Companies shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Alcon has higher revenue and earnings than Cooper Companies. Alcon is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Alcon	$10.40B	3.50	$980M	$1.31	56.25
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.24

In the previous week, Cooper Companies had 32 more articles in the media than Alcon. MarketBeat recorded 34 mentions for Cooper Companies and 2 mentions for Alcon. Cooper Companies' average media sentiment score of 1.06 beat Alcon's score of 0.41 indicating that Cooper Companies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Alcon	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Neutral
Cooper Companies	23 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Alcon has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, indicating that its stock price is 17% less volatile than the broader market.

Alcon has a net margin of 5.92% compared to Cooper Companies' net margin of 5.57%. Cooper Companies' return on equity of 10.88% beat Alcon's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Alcon	5.92%	7.29%	5.09%
Cooper Companies	5.57%	10.88%	7.27%

Summary

Alcon beats Cooper Companies on 10 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Medline?

Cooper Companies (NASDAQ:COO) and Medline (NASDAQ:MDLN) are both large-cap healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their profitability, risk, media sentiment, earnings, dividends, analyst recommendations, institutional ownership and valuation.

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by insiders. Comparatively, 0.8% of Medline shares are held by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company is poised for long-term growth.

In the previous week, Cooper Companies had 23 more articles in the media than Medline. MarketBeat recorded 34 mentions for Cooper Companies and 11 mentions for Medline. Cooper Companies' average media sentiment score of 1.06 beat Medline's score of 0.20 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	23 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Medline	3 Very Positive mention(s)	1 Positive mention(s)	5 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

Cooper Companies currently has a consensus target price of $81.64, indicating a potential upside of 7.71%. Medline has a consensus target price of $47.42, indicating a potential upside of 36.67%. Given Medline's stronger consensus rating and higher probable upside, analysts clearly believe Medline is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Medline	1 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	2 Strong Buy rating(s)	2.83

Medline has higher revenue and earnings than Cooper Companies. Medline is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.24
Medline	$28.43B	1.60	$1.16B	$0.79	43.92

Cooper Companies has a net margin of 5.57% compared to Medline's net margin of 0.00%. Cooper Companies' return on equity of 10.88% beat Medline's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Medline	N/A	N/A	N/A

Summary

Cooper Companies beats Medline on 10 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to West Pharmaceutical Services?

West Pharmaceutical Services (NYSE:WST) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, valuation, institutional ownership, media sentiment, risk, profitability, dividends and analyst recommendations.

93.9% of West Pharmaceutical Services shares are owned by institutional investors. Comparatively, 24.4% of Cooper Companies shares are owned by institutional investors. 0.6% of West Pharmaceutical Services shares are owned by insiders. Comparatively, 2.1% of Cooper Companies shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

West Pharmaceutical Services has a net margin of 16.98% compared to Cooper Companies' net margin of 5.57%. West Pharmaceutical Services' return on equity of 20.11% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
West Pharmaceutical Services	16.98%	20.11%	14.83%
Cooper Companies	5.57%	10.88%	7.27%

West Pharmaceutical Services has higher earnings, but lower revenue than Cooper Companies. West Pharmaceutical Services is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
West Pharmaceutical Services	$3.33B	7.47	$493.70M	$7.81	45.24
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.24

West Pharmaceutical Services currently has a consensus target price of $368.08, suggesting a potential upside of 4.17%. Cooper Companies has a consensus target price of $81.64, suggesting a potential upside of 7.71%. Given Cooper Companies' higher possible upside, analysts clearly believe Cooper Companies is more favorable than West Pharmaceutical Services.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
West Pharmaceutical Services	0 Sell rating(s)	3 Hold rating(s)	11 Buy rating(s)	1 Strong Buy rating(s)	2.87
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

West Pharmaceutical Services has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, indicating that its share price is 17% less volatile than the broader market.

In the previous week, Cooper Companies had 14 more articles in the media than West Pharmaceutical Services. MarketBeat recorded 34 mentions for Cooper Companies and 20 mentions for West Pharmaceutical Services. West Pharmaceutical Services' average media sentiment score of 1.70 beat Cooper Companies' score of 1.06 indicating that West Pharmaceutical Services is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
West Pharmaceutical Services	20 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Very Positive
Cooper Companies	23 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

Summary

West Pharmaceutical Services beats Cooper Companies on 11 of the 16 factors compared between the two stocks.

How does Cooper Companies compare to Solventum?

Cooper Companies (NASDAQ:COO) and Solventum (NYSE:SOLV) are both large-cap healthcare companies, but which is the superior investment? We will contrast the two companies based on the strength of their earnings, media sentiment, dividends, profitability, institutional ownership, analyst recommendations, risk and valuation.

In the previous week, Cooper Companies had 30 more articles in the media than Solventum. MarketBeat recorded 34 mentions for Cooper Companies and 4 mentions for Solventum. Cooper Companies' average media sentiment score of 1.06 beat Solventum's score of 0.95 indicating that Cooper Companies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Cooper Companies	23 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive
Solventum	1 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

24.4% of Cooper Companies shares are held by institutional investors. 2.1% of Cooper Companies shares are held by company insiders. Comparatively, 0.2% of Solventum shares are held by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company will outperform the market over the long term.

Solventum has a net margin of 17.26% compared to Cooper Companies' net margin of 5.57%. Solventum's return on equity of 25.09% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cooper Companies	5.57%	10.88%	7.27%
Solventum	17.26%	25.09%	8.78%

Cooper Companies currently has a consensus target price of $81.64, suggesting a potential upside of 7.71%. Solventum has a consensus target price of $91.64, suggesting a potential upside of 0.46%. Given Cooper Companies' higher possible upside, research analysts clearly believe Cooper Companies is more favorable than Solventum.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35
Solventum	1 Sell rating(s)	4 Hold rating(s)	8 Buy rating(s)	0 Strong Buy rating(s)	2.54

Solventum has higher revenue and earnings than Cooper Companies. Solventum is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.24
Solventum	$8.31B	1.87	$1.56B	$8.18	11.15

Cooper Companies has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, Solventum has a beta of 0.6, meaning that its stock price is 40% less volatile than the broader market.

Summary

Cooper Companies beats Solventum on 9 of the 17 factors compared between the two stocks.

How does Cooper Companies compare to Align Technology?

Align Technology (NASDAQ:ALGN) and Cooper Companies (NASDAQ:COO) are both large-cap healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, risk, dividends, institutional ownership, earnings, profitability, valuation and media sentiment.

Align Technology has a beta of 1.65, suggesting that its stock price is 65% more volatile than the broader market. Comparatively, Cooper Companies has a beta of 0.83, suggesting that its stock price is 17% less volatile than the broader market.

In the previous week, Cooper Companies had 24 more articles in the media than Align Technology. MarketBeat recorded 34 mentions for Cooper Companies and 10 mentions for Align Technology. Align Technology's average media sentiment score of 1.17 beat Cooper Companies' score of 1.06 indicating that Align Technology is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Align Technology	8 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Cooper Companies	23 Very Positive mention(s)	3 Positive mention(s)	5 Neutral mention(s)	2 Negative mention(s)	1 Very Negative mention(s)	Positive

88.4% of Align Technology shares are held by institutional investors. Comparatively, 24.4% of Cooper Companies shares are held by institutional investors. 0.8% of Align Technology shares are held by company insiders. Comparatively, 2.1% of Cooper Companies shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Align Technology has a net margin of 9.99% compared to Cooper Companies' net margin of 5.57%. Align Technology's return on equity of 15.86% beat Cooper Companies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Align Technology	9.99%	15.86%	10.32%
Cooper Companies	5.57%	10.88%	7.27%

Align Technology presently has a consensus target price of $206.36, suggesting a potential upside of 29.26%. Cooper Companies has a consensus target price of $81.64, suggesting a potential upside of 7.71%. Given Align Technology's stronger consensus rating and higher possible upside, equities research analysts clearly believe Align Technology is more favorable than Cooper Companies.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Align Technology	0 Sell rating(s)	6 Hold rating(s)	8 Buy rating(s)	1 Strong Buy rating(s)	2.67
Cooper Companies	3 Sell rating(s)	6 Hold rating(s)	7 Buy rating(s)	1 Strong Buy rating(s)	2.35

Align Technology has higher earnings, but lower revenue than Cooper Companies. Align Technology is trading at a lower price-to-earnings ratio than Cooper Companies, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Align Technology	$4.14B	2.76	$410.35M	$5.75	27.76
Cooper Companies	$4.23B	3.49	$374.90M	$1.18	64.24

Summary

Align Technology beats Cooper Companies on 11 of the 16 factors compared between the two stocks.

Get Cooper Companies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding COO and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

COO vs. The Competition

Export

Metric	Cooper Companies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$14.78B	$5.84B	$7.29B	$12.70B
Dividend Yield	N/A	1.75%	2.54%	10.79%
P/E Ratio	64.24	26.16	271.38	24.10
Price / Sales	3.49	69.41	638.44	90.36
Price / Cash	12.59	33.71	29.03	36.90
Price / Book	1.83	6.18	11.18	6.40
Net Income	$374.90M	$149.30M	$3.46B	$348.28M
7 Day Performance	0.93%	0.94%	1.99%	0.91%
1 Month Performance	7.81%	8.88%	7.32%	5.10%
1 Year Performance	0.77%	7.25%	24.76%	16.16%

Cooper Companies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
COO Cooper Companies	2.8364 of 5 stars	$75.80 -0.6%	$81.64 +7.7%	+1.3%	$14.78B	$4.23B	64.24	15,000
ALC Alcon	3.1702 of 5 stars	$74.23 +1.0%	$84.63 +14.0%	-10.3%	$36.72B	$10.40B	56.66	25,942
MDLN Medline	3.5076 of 5 stars	$35.76 +0.5%	$47.42 +32.6%	N/A	$47.00B	$29.94B	45.28	45,000
WST West Pharmaceutical Services	3.7908 of 5 stars	$346.73 +0.2%	$368.08 +6.2%	+42.6%	$24.40B	$3.07B	44.40	10,800	Positive News
SOLV Solventum	2.6013 of 5 stars	$87.43 +1.1%	$91.64 +4.8%	+22.0%	$14.88B	$8.33B	10.69	20,000	Analyst Downgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:COO) was last updated on 8/24/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Cooper Companies (COO) Competitors

COO vs. ALC, MDLN, WST, SOLV, and ALGN

How does Cooper Companies compare to Alcon?

Summary

How does Cooper Companies compare to Medline?

Summary

How does Cooper Companies compare to West Pharmaceutical Services?

Summary

How does Cooper Companies compare to Solventum?

Summary

How does Cooper Companies compare to Align Technology?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COO vs. The Competition

Cooper Companies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

Cooper Companies (COO) Competitors

COO vs. ALC, MDLN, WST, SOLV, and ALGN

How does Cooper Companies compare to Alcon?

Do analysts prefer ALC or COO?

Do insiders & institutionals have more ownership in ALC or COO?

Which has stronger earnings and valuation, ALC or COO?

Does the media prefer ALC or COO?

Which has more risk & volatility, ALC or COO?

Is ALC or COO more profitable?

Summary

How does Cooper Companies compare to Medline?

Do insiders and institutionals believe in COO or MDLN?

Does the media prefer COO or MDLN?

Do analysts prefer COO or MDLN?

Which has preferable earnings and valuation, COO or MDLN?

Is COO or MDLN more profitable?

Summary

How does Cooper Companies compare to West Pharmaceutical Services?

Do institutionals & insiders have more ownership in WST or COO?

Is WST or COO more profitable?

Which has better earnings & valuation, WST or COO?

Do analysts recommend WST or COO?

Which has more volatility and risk, WST or COO?

Does the media refer more to WST or COO?

Summary

How does Cooper Companies compare to Solventum?

Does the media favor COO or SOLV?

Do institutionals and insiders have more ownership in COO or SOLV?

Is COO or SOLV more profitable?

Do analysts prefer COO or SOLV?

Which has stronger earnings & valuation, COO or SOLV?

Which has more volatility & risk, COO or SOLV?

Summary

How does Cooper Companies compare to Align Technology?

Which has more risk & volatility, ALGN or COO?

Does the media prefer ALGN or COO?

Do insiders and institutionals hold more shares of ALGN or COO?

Is ALGN or COO more profitable?

Do analysts rate ALGN or COO?

Which has preferable earnings & valuation, ALGN or COO?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

COO vs. The Competition

Cooper Companies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools